neostigmine has been researched along with Bodily Distress Disorder in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PRESWICK, G | 1 |
| HENDERSON, AS | 1 |
| Schwab, RS | 1 |
| Perlo, VP | 1 |
2 other studies available for neostigmine and Bodily Distress Disorder
| Article | Year |
|---|---|
MYASTHENIA AND THE "ASTHENIC" SYNDROME.
Topics: Diagnosis, Differential; Drug Therapy; Humans; Hysteria; Mental Disorders; Muscular Diseases; Myasth | 1965 |
Syndromes simulating myasthenia gravis.
Topics: Adult; Aged; Brain Diseases; Brain Stem; Diagnosis, Differential; Edrophonium; Extrapyramidal Tracts | 1966 |